CYP2D6 polymorphisms influence tamoxifen treatment outcomes in
Por um escritor misterioso
Descrição
Frontiers Improved Prediction of Endoxifen Metabolism by CYP2D6 Genotype in Breast Cancer Patients Treated with Tamoxifen
CYP2D6 genotype- and endoxifen-guided tamoxifen dose escalation increases endoxifen serum concentrations without increasing side effects. - Abstract - Europe PMC
CYP2D6 gene polymorphisms in Brazilian patients with breast cancer treated with adjuvant tamoxifen and its association with disease recurrence
CYP2D6 genotype predicts tamoxifen discontinuation and drug response: a secondary analysis of the KARISMA trial - ScienceDirect
Pharmacogenetics and Psychiatric Care: A Review and Commentary
Influence of CYP2D6, CYP2C19 and CYP3A5 polymorphisms on plasma levels of tamoxifen metabolites in Algerian women with ER+ breast cancer, Egyptian Journal of Medical Human Genetics
Bioavailability and Pharmacokinetics of Endoxifen in Female Rats and Dogs: Evidence to Support the Use of Endoxifen to Overcome the Limitations of CYP2D6-Mediated Tamoxifen Metabolism
JPM, Free Full-Text
CYP2D6: Unveiling the Mysteries of this Key Enzyme - FasterCapital
de
por adulto (o preço varia de acordo com o tamanho do grupo)
